These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 8629887)

  • 1. Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression.
    Miller HL; Delgado PL; Salomon RM; Berman R; Krystal JH; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1996 Feb; 53(2):117-28. PubMed ID: 8629887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine dysfunction and the pathophysiology and treatment of depression.
    Charney DS
    J Clin Psychiatry; 1998; 59 Suppl 14():11-4. PubMed ID: 9818625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms: implications for the neural circuitry of depression.
    Bremner JD; Vythilingam M; Ng CK; Vermetten E; Nazeer A; Oren DA; Berman RM; Charney DS
    JAMA; 2003 Jun; 289(23):3125-34. PubMed ID: 12813118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test.
    O'Leary OF; Bechtholt AJ; Crowley JJ; Hill TE; Page ME; Lucki I
    Psychopharmacology (Berl); 2007 Jun; 192(3):357-71. PubMed ID: 17318507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noradrenaline and serotonin reuptake inhibition as clinical principles: a review of antidepressant efficacy.
    Humble M
    Acta Psychiatr Scand Suppl; 2000; 402():28-36. PubMed ID: 10901156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sertraline: a new antidepressant.
    Auster R
    Am Fam Physician; 1993 Aug; 48(2):311-4. PubMed ID: 8342482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norepinephrine involvement in antidepressant action.
    Frazer A
    J Clin Psychiatry; 2000; 61 Suppl 10():25-30. PubMed ID: 10910014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duloxetine pharmacology: profile of a dual monoamine modulator.
    Karpa KD; Cavanaugh JE; Lakoski JM
    CNS Drug Rev; 2002; 8(4):361-76. PubMed ID: 12481192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition.
    Jones CK; Eastwood BJ; Need AB; Shannon HE
    Neuropharmacology; 2006 Dec; 51(7-8):1172-80. PubMed ID: 17045620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action.
    Delgado PL; Miller HL; Salomon RM; Licinio J; Krystal JH; Moreno FA; Heninger GR; Charney DS
    Biol Psychiatry; 1999 Jul; 46(2):212-20. PubMed ID: 10418696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of sertraline in the management of depression.
    Shelton RC
    Clin Ther; 1994; 16(5):768-82; discussion 767. PubMed ID: 7859236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noradrenergic versus serotonergic antidepressants: predictors of treatment response.
    Schatzberg AF
    J Clin Psychiatry; 1998; 59 Suppl 14():15-8. PubMed ID: 9818626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study.
    Nelson JC; Mazure CM; Jatlow PI; Bowers MB; Price LH
    Biol Psychiatry; 2004 Feb; 55(3):296-300. PubMed ID: 14744472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.
    Barr LC; Goodman WK; Anand A; McDougle CJ; Price LH
    Am J Psychiatry; 1997 Sep; 154(9):1293-5. PubMed ID: 9286191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation strategies with serotonergic-noradrenergic combinations.
    Nelson JC
    J Clin Psychiatry; 1998; 59 Suppl 5():65-8; discussion 69. PubMed ID: 9635550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of norepinephrine metabolism with desipramine and zimelidine in depressed patients.
    Linnoila M; Karoum F; Calil HM; Kopin IJ; Potter WZ
    Arch Gen Psychiatry; 1982 Sep; 39(9):1025-8. PubMed ID: 6214234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
    Sánchez C; Hyttel J
    Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of desipramine coadministered with sertraline or fluoxetine.
    Preskorn SH; Alderman J; Chung M; Harrison W; Messig M; Harris S
    J Clin Psychopharmacol; 1994 Apr; 14(2):90-8. PubMed ID: 8195463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors.
    Cryan JF; O'Leary OF; Jin SH; Friedland JC; Ouyang M; Hirsch BR; Page ME; Dalvi A; Thomas SA; Lucki I
    Proc Natl Acad Sci U S A; 2004 May; 101(21):8186-91. PubMed ID: 15148402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamines and the mechanism of antidepressant action: effects of catecholamine depletion on mood of patients treated with antidepressants.
    Delgado PL; Miller HL; Salomon RM; Licinio J; Heninger GR; Gelenberg AJ; Charney DS
    Psychopharmacol Bull; 1993; 29(3):389-96. PubMed ID: 8121966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.